Poor anticoagulation control in warfarin treated atrial fibrillation patients with reduced renal function

Anders Nissen Bonde; Professor Gregory Lip; Anne‐Lise Kamper; Laila Stærk; Christian Torp‐Pedersen; Gunnar Gislason; Jonas Bjerring Olesen

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry

Liang Hai-feng, Xin Du, Yingchun Zhou, Xiaoyi Yang, Shijun Xia, Jianzeng Dong, Professor Gregory Lip, Changsheng Ma

Article2019

BS58 Does change in renal function affect warfarin’s efficacy in patients with atrial fibrillation?

Ahsan Ali Khan, Eduard Shantsila, Yee Cheng Lau, Lewis Hardy, Helen Philippou, Professor Gregory Lip

Article2017

Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists

José María Lobos-Bejarano, Ángel Castellanos Rodríguez, Vivencio Barrios, Carlos Escobar, José Polo García, José Carlos del Castillo-Rodríguez, Diego Vargas-Ortega, Adriana López‐Pineda, Luís Prieto, Professor Gregory Lip

Article2017

Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries

Anders Nissen Bonde, Professor Gregory Lip, Anne‐Lise Kamper, Laila Stærk, Christian Torp‐Pedersen, Gunnar Gislason, Jonas Bjerring Olesen

Article2016

Outcomes in a Warfarin-Treated Population With Atrial Fibrillation

Fredrik Björck, Henrik Renlund, Professor Gregory Lip, Per Wester, Peter J Svensson, Anders Själander